Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp. (BPM) is a clinical IVD company, focusing on translating validated and IP-protected novel biomarkers into diagnostic solutions of disease’s early detection/ prevention for unmet clinical need. Our DNlite-IVD103, which detecting a specific DKD (Diabetic Kidney Disease) biomarker, is the world first regulatory approved (CE-IVD) ELISA test for predicting/ monitoring the progression of DKD. In addition to DNlite-IVD103, BPM will launch series of IVD tests for DKD, renal injury, diabetes related heart complications (CVD), and oncology (GI cancer). www.bpmbiotech.com